Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

Shares in biotech group Xilio Therapeutics (XLO) surged over 125% today after it sealed a cancer-fighting deal with AbbVie Inc. (ABBV). The two companies announced a collaboration and option-to ...

XLO opened at $0.73 on Thursday. The company has a market capitalization of $37.86 million, a P/E ratio of -0.43 and a beta of -0.38. The company has a 50-day moving average of $0.85 and a 200-day ...

ByInvesting.com • Apr 08, 2025 XLO stock touches 52-week low at $0.62 amid market challenges In a challenging market environment, Xilio Development’s stock (XLO) has recorded a new 52-week low ...

Short interest in Xilio Therapeutics Inc (NASDAQ:XLO) increased during the last reporting period, rising from 575.45K to 644.54K. This put 1.46% of the company's publicly available shares short.